Table 2.
Antifungal susceptibility of otomycosis agents (Candida species)
| Species | Antifungals | MIC | Resistant (%) |
|---|---|---|---|
| Candida albicans (3) | Terbinafine | 4 | 0 (0.0%) |
| Caspofungin | 0.5-1 | 1 (33.3%) | |
| Fluconazole | 4-16 | 2 (66.7%) | |
| Itraconazole | 0.5-4 | 1 (33.3%) | |
| Miconazole | 0.5-4 | - | |
| Bifonazole | 8-16 | - | |
| Econazole | 0.0625-0.5 | - | |
| C. glabrata (3) | Terbinafine | 2-8 | 0 (0.0%) |
| Caspofungin | 0.5-2 | 3 (100%) | |
| Fluconazole | 1-32 | 0 (0.0%) | |
| Itraconazole | 0.0625-8 | 2 (66.7%) | |
| Miconazole | 0.25-4 | - | |
| Bifonazole | 4-16 | - | |
| Econazole | 0.0625-1 | - | |
| Candida species (3) | Terbinafine | 0.0625-1 | 0 (0.0%) |
| Caspofungin | 1-2 | 3 (100%) | |
| Fluconazole | 2-16 | 1 (33.3%) | |
| Itraconazole | 0.0625-0.25 | 0 (0.0%) | |
| Miconazole | 2-4 | - | |
| Bifonazole | 2-8 | - | |
| Econazole | 0.0625-1 | - | |
| Total (9) | Terbinafine | 0.0625-8 | 0 (0.0%) |
| Caspofungin | 0.5-2 | 7 (77.8%) | |
| Fluconazole | 1-32 | 3 (33.3%) | |
| Itraconazole | 0.0625-8 | 3 (33.3%) | |
| Miconazole | 0.25-4 | - | |
| Bifonazole | 2-16 | - | |
| Econazole | 0.0625-1 | - |